Allogene Therapeutics, Inc.
Overview
Allogene Therapeutics, Inc. is a biotechnology company specializing in the development of allogeneic CAR T-cell therapies for cancer treatment. The company is committed to delivering safe, efficient, and accessible therapies to patients with cancer and aims to transform the CAR T landscape.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Allogene Therapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Allogene Therapeutics, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.